BioCryst Pharmaceuticals, Inc. (BMV:BCRX)
Mexico flag Mexico · Delayed Price · Currency is MXN
197.50
-3.50 (-1.74%)
At close: May 23, 2025

Arcadium Lithium Market Cap

BioCryst Pharmaceuticals has a market cap or net worth of 32.29 billion as of August 11, 2025. Its market cap has increased by 14.99% in one year.

Market Cap
32.29B
Enterprise Value
42.19B
Revenue
10.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
$197.50

Market Cap Chart

Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 69.93M to 32.29B, an increase of 46,078.48%. That is a compound annual growth rate of 21.54%.

History

DateMarket Cap% Change
Aug 8, 202532.29B-0.51%
Dec 31, 202432.46B56.49%
Dec 29, 202320.74B-50.32%
Dec 30, 202241.75B-18.29%
Dec 31, 202151.09B95.19%
Dec 31, 202026.17B161.10%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition